Literature DB >> 33848942

Rethinking 'carriage' of take-home naloxone.

Rebecca McDonald1, Stephen Parkin1, Desiree Eide2, Joanne Neale1, Thomas Clausen3, Nicola Metrebian1, Ben Carter4, John Strang5.   

Abstract

Take-home naloxone (THN) provision to people who use drugs, their family/friends, and non-medical personnel is considered a public health strategy to improve community-based naloxone access and reduce the time to antidote treatment for opioid overdose in order to prevent fatal outcome. THN programs typically report up to three performance indicators: the volume of THN kits distributed, the rate of requests for re-supply of THN kits (e.g., following naloxone use for overdose reversal), and - increasingly - THN "carriage". In this Research Methods piece, we discuss the current shortcomings in the latter measurement of THN carriage from a mixed-methods perspective and describe possible implications for public health related research and improved data analyses. We present an argument for the need to improve research methods in the case of THN "carriage" and propose a multidimensional measurement structure that takes into account: 1) the location of the THN kit relative to its owner, 2) the owner's immediate access to the kit in an emergency, 3) the type of THN device, and 4) the purpose of THN ownership (i.e., for use in self or known/unknown other/s).
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Harm reduction; Measurement; Naloxone; Opioid; Overdose; Research methods

Year:  2021        PMID: 33848942     DOI: 10.1016/j.drugpo.2021.103253

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  1 in total

1.  Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.

Authors:  Alexis V Rivera; Michelle L Nolan; Denise Paone; Sidney A Carrillo; Sarah L Braunstein
Journal:  Subst Abus       Date:  2022       Impact factor: 3.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.